These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1739581)

  • 1. Advances in alopecia areata and androgenetic alopecia.
    Sawaya ME; Hordinsky MK
    Adv Dermatol; 1992; 7():211-26; discussion 227. PubMed ID: 1739581
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte subpopulations in alopecia areata and psoriasis: identification with monoclonal antibodies and Fc receptors.
    Gu SQ; Petrini B; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1983; 63(3):244-6. PubMed ID: 6192643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative activity and regulatory subpopulations of T lymphocytes in various forms of alopecia].
    Kulagin Vi; Cheredeev AN; Liakhov VF
    Vestn Dermatol Venerol; 1988; (1):10-4. PubMed ID: 2966508
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata.
    Ito T; Fujiyama T; Hashizume H; Tokura Y
    J Dermatol Sci; 2013 Oct; 72(1):68-71. PubMed ID: 23735349
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathogenesis of folliculitis decalvans: clues in early lesions.
    Chiarini C; Torchia D; Bianchi B; Volpi W; Caproni M; Fabbri P
    Am J Clin Pathol; 2008 Oct; 130(4):526-34. PubMed ID: 18794044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocytes in alopecia areata].
    Szczeklik-Franek A; Musiałowicz D; Włoszczuk-Szulc H; Huzarski J
    Przegl Dermatol; 1981; 68(4):447-51. PubMed ID: 6977139
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current trends in hair diseases].
    Merk H
    Z Hautkr; 1985 Aug; 60(15):1169-72. PubMed ID: 4049987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thymopentin in alopecia areata].
    Gruber DM; Sator MO; Kokoschka EM; Huber JC
    Acta Med Austriaca; 1998; 25(1):33-5. PubMed ID: 9576023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T and B lymphocytes in DNCB-treated alopecia areata (author's transl)].
    Cisło M; Wasik F; Bliźanowska A
    Dermatol Monatsschr; 1981 Jun; 167(6):356-61. PubMed ID: 6974106
    [No Abstract]   [Full Text] [Related]  

  • 12. Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire among infiltrating lymphocytes.
    Dressel D; Brütt CH; Manfras B; Zollner TM; Wunderlich A; Böhm BO; Boehncke WH
    J Cutan Pathol; 1997 Mar; 24(3):164-8. PubMed ID: 9085152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 expression in alopecia areata and androgenetic alopecia.
    Sawaya ME; Bakshandeh H; Hordinsky MK; Penneys NS
    J Cutan Pathol; 1994 Jun; 21(3):229-32. PubMed ID: 7525670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum BAFF and APRIL levels in patients with alopecia areata.
    Kuwano Y; Fujimoto M; Watanabe R; Ishiura N; Nakashima H; Ohno Y; Yano S; Yazawa N; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Jun; 50(3):236-9. PubMed ID: 18328673
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata.
    Perret C; Wiesner-Menzel L; Happle R
    Acta Derm Venereol; 1984; 64(1):26-30. PubMed ID: 6203277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective changes in lymphocytic differentiation antigens in the peripheral blood of patients with alopecia areata treated with oral zinc].
    Lutz G; Kreysel HW
    Z Hautkr; 1990 Feb; 65(2):132-4, 137-8. PubMed ID: 1971470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological study of alopecia areata].
    Wüthrich B; Grob PJ; Zisiadis S
    Hautarzt; 1980 Sep; 31(9):495-501. PubMed ID: 6969719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata and vitiligo associated with Down's syndrome.
    Brown AC; Olkowski ZL; McLaren JR; Kutner MH
    Arch Dermatol; 1977 Sep; 113(9):1296. PubMed ID: 143244
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: association with autoantibodies.
    Lowy M; Ledoux-Corbusier M; Achten G; Wybran J
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):78-84. PubMed ID: 2579988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.